NO20080445L - Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer - Google Patents
Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommerInfo
- Publication number
- NO20080445L NO20080445L NO20080445A NO20080445A NO20080445L NO 20080445 L NO20080445 L NO 20080445L NO 20080445 A NO20080445 A NO 20080445A NO 20080445 A NO20080445 A NO 20080445A NO 20080445 L NO20080445 L NO 20080445L
- Authority
- NO
- Norway
- Prior art keywords
- gastrointestinal disorders
- treatment
- receptor antagonists
- neurokinin receptor
- azetidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0501494 | 2005-06-23 | ||
| PCT/SE2006/000759 WO2006137790A1 (en) | 2005-06-23 | 2006-06-21 | New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080445L true NO20080445L (no) | 2008-01-23 |
Family
ID=37570728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080445A NO20080445L (no) | 2005-06-23 | 2008-01-23 | Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100069346A1 (xx) |
| EP (1) | EP1899326A4 (xx) |
| JP (1) | JP2009501144A (xx) |
| KR (1) | KR20080036957A (xx) |
| CN (1) | CN101203511A (xx) |
| AU (1) | AU2006259891A1 (xx) |
| CA (1) | CA2612133A1 (xx) |
| IL (1) | IL187966A0 (xx) |
| MX (1) | MX2007015606A (xx) |
| NO (1) | NO20080445L (xx) |
| WO (1) | WO2006137790A1 (xx) |
| ZA (1) | ZA200710611B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR057828A1 (es) * | 2005-09-29 | 2007-12-19 | Astrazeneca Ab | Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica |
| WO2007136325A1 (en) * | 2006-05-18 | 2007-11-29 | Astrazeneca Ab | 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 2 |
| US8106208B2 (en) * | 2006-05-18 | 2012-01-31 | Albireo Ab | Benzamide compounds that act as NK receptor antagonists |
| WO2007136326A2 (en) * | 2006-05-18 | 2007-11-29 | Astrazeneca Ab | ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3 |
| KR101558005B1 (ko) * | 2007-03-08 | 2015-10-06 | 알비레오 에이비 | 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도 |
| WO2008118092A1 (en) * | 2007-03-28 | 2008-10-02 | Albireo Ab | Maleate salt of 3-bromo-n-{ (2s) -2- (4-f luorophenyl) -4- [3- (4-acetylpiperazin-1-yl) azetidin-1-yl] butyl} -methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders |
| WO2008118091A1 (en) * | 2007-03-28 | 2008-10-02 | Albireo Ab | A fumarate salt of 3-bromo-n-{ (2s) -2- (4 -fluorophenyl) -4- [3- (4-acetylpiperazin-l-yl) azetidin-1-yl] butyl} -n-methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| CN102459166B (zh) * | 2009-04-22 | 2015-03-25 | 詹森药业有限公司 | 作为单酰甘油脂肪酶抑制剂的氮杂环丁烷基二酰胺 |
| US20120295942A1 (en) | 2010-02-01 | 2012-11-22 | Nicholas James Devereux | Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists |
| WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
| ES2527849T3 (es) | 2010-02-02 | 2015-01-30 | Novartis Ag | Derivados de ciclohexilamida como antagonistas del receptor de CRF |
| CN105663133B (zh) * | 2016-03-07 | 2019-06-25 | 青岛市肿瘤医院 | 一种抑制淋巴瘤细胞增殖的药物组合物及其应用 |
| ES2970361T3 (es) | 2019-05-24 | 2024-05-28 | Irl 790 Ab | Sales de ácido tartárico de [2-(3-fluoro-5-metanosulfonilfenoxi)etil](propil)amina |
| EP4243801A1 (en) | 2020-11-10 | 2023-09-20 | Integrative Research Laboratories Sweden AB | [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (mesdopetam) for use in the prevention or reduction of sensitization to a pharmaceutical drug for parkinson's disease, in particular l-dopa induced dyskinesias |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| GB9601202D0 (en) * | 1996-01-22 | 1996-03-20 | Pfizer Ltd | Piperidones |
| IL140770A0 (en) * | 1998-07-10 | 2002-02-10 | Astrazeneca Ab | N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| GB9922519D0 (en) * | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
| TW200508221A (en) * | 2003-06-13 | 2005-03-01 | Astrazeneca Ab | New azetidine compounds |
-
2006
- 2006-06-21 AU AU2006259891A patent/AU2006259891A1/en not_active Abandoned
- 2006-06-21 WO PCT/SE2006/000759 patent/WO2006137790A1/en active Application Filing
- 2006-06-21 KR KR1020077030086A patent/KR20080036957A/ko not_active Application Discontinuation
- 2006-06-21 US US11/993,361 patent/US20100069346A1/en not_active Abandoned
- 2006-06-21 CA CA002612133A patent/CA2612133A1/en not_active Abandoned
- 2006-06-21 MX MX2007015606A patent/MX2007015606A/es not_active Application Discontinuation
- 2006-06-21 JP JP2008518081A patent/JP2009501144A/ja not_active Abandoned
- 2006-06-21 CN CNA2006800226798A patent/CN101203511A/zh active Pending
- 2006-06-21 EP EP06747948A patent/EP1899326A4/en not_active Withdrawn
-
2007
- 2007-12-05 ZA ZA200710611A patent/ZA200710611B/xx unknown
- 2007-12-06 IL IL187966A patent/IL187966A0/en unknown
-
2008
- 2008-01-23 NO NO20080445A patent/NO20080445L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1899326A1 (en) | 2008-03-19 |
| IL187966A0 (en) | 2008-03-20 |
| CN101203511A (zh) | 2008-06-18 |
| MX2007015606A (es) | 2008-02-25 |
| ZA200710611B (en) | 2008-11-26 |
| WO2006137790A1 (en) | 2006-12-28 |
| CA2612133A1 (en) | 2006-12-28 |
| JP2009501144A (ja) | 2009-01-15 |
| AU2006259891A1 (en) | 2006-12-28 |
| US20100069346A1 (en) | 2010-03-18 |
| KR20080036957A (ko) | 2008-04-29 |
| EP1899326A4 (en) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080445L (no) | Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer | |
| NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20061137L (no) | Cyklopropylderivater som NK3-reseptorantagonister | |
| NO20080981L (no) | Nitrocatechol-derivater som COMT-inhibitorer | |
| NO20055219L (no) | Nye forbindelser | |
| NO20080408L (no) | Azaindazolforbindelser og anvendelse derav | |
| EA200601266A1 (ru) | Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| NO20071593L (no) | Pyrimidinderivater | |
| EA201000549A1 (ru) | Производные пиперидина и пиперазина | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| DE602006010243D1 (de) | 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen | |
| NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
| NO20083568L (no) | Hydantoinforbindelser for behandling av inflammatoriske forstyrrelser | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| NO20081434L (no) | 5-(fenylisoksazolyletoksy)-triazol-3-yl substituert pyridinsammensetninger for behandling av neurologisk, psykiatrisk eller smerteforstyrrelser | |
| CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
| NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
| TW200720260A (en) | Prokineticin 1 receptor antagonists | |
| NO20076424L (no) | N-koblete heterocykliske antagonister av P2Y1 reseptoren nyttige for behandling av tromboseforstyrrelser | |
| EA200970341A1 (ru) | Пиразолиновые соединения в качестве антагонистов минералокортикоидных рецепторов | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |